Cannabis Law Report

FEBRUARY 15, 2019

Under strict manufacturing and pharmaceutical standards, 400 grammes of Bedrocan cannabis and 400 grammes of Bedica grown by Dutch biopharmaceutical firm, Bedrocan, was imported by IPS Specials following prescriptions issued for chronic pain at a cost of £695 per private patient. . And even then they risked having it seized at customs.

History 56

History Legalization Chronic Pain Pharmaceutical 56

Veriheal

MARCH 7, 2023

During the inauguration, Georgiadis noted that Greek patients stand to benefit from using plant-produced medicines, despite cannabis “having a difficult history due to its nature as a narcotic.” The CEO of Tikun Europe, Nikos Beis, also shared his views on the launch of Greece’s medicinal cannabis production plant.

Marijuana 98

Marijuana Pharmaceutical Medicine Cultivation 98

Cannabis Law Report

JANUARY 23, 2022

Claire gained substantial pharmaceutical experience from her work in the biotechnology industry before transferring to cannabis in 2017. I look forward to leading the Lophos team and respectfully adding to Peyote’s proud history,” said Claire Stawnyczy, CEO of Lophos. “We Greenridez 2.0 Acquisitions Corp.

History 52

History Pharmaceutical Compliance Compliance 52

The Cannigma

JUNE 25, 2022

The country has strict prohibition laws, and violating these can come with fines or hefty jail sentences. While the plant has deep roots in the country and was used throughout history, it was prohibited in the 20 th century. These products are typically more accessible in larger cities. Medical: Yes Recreational: No.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. Further, numerous private companies have begun to research psychedelic therapy and develop new pharmaceutical compounds derived from psychedelic substances. Some of the most promising substances, and the law applicable to each, are outlined below: Psilocybin.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

DECEMBER 2, 2021

Equity subcommittee members raised concerns regarding the background check requirement, expressing worry such a requirement will disparately impact individuals from communities disproportionately targeted by law enforcement. Programs shall train students on how to proactively make psilocybin services accessible to people with disabilities.

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

FEBRUARY 25, 2022

The company’s EU-GMP medicinal marijuana products are currently accessible in pharmacies in Malta, ensuring that patients have safe and dependable access to high-quality marijuana. (NASDAQ: TLRY) has announced that its medical unit, Tilray Medical, has finalized the first sales of medical marijuana in Malta.

Medicine 52

Medicine Access Patients Pharmaceutical 52

Veriheal

JUNE 29, 2021

Plant medicines and concoctions made from them have been utilized throughout the history of cultures around the world. In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. A Push by Patients.

Therapy 55

Therapy DEA Patients Clinical Trials 55

Cannabis Law Report

AUGUST 16, 2021

People are investing less than they used to since the pharmaceutical sector has seen a significant drop in recent years. Cannabis has risen from the shadows of stoner culture as a multi-billion dollar business with roots in industries such as healthcare, pharmaceuticals, consumer products, and agriculture.

Business 105

Business eCommerce Media Pharmaceutical 105

FloridaMarijuana.net

JULY 16, 2018

No need to take pills that could do more harm than good; or deal with painful side effects that pharmaceuticals cause. It’s important to remember that while the use of medical marijuana is allowed in the state of Florida, the federal law still classifies cannabis as a schedule 1 drug. Medical records & History.

Marijuana 189

Marijuana Patients Conditions Treatment 189

Cannabis Law Report

AUGUST 31, 2021

People are investing less than they used to since the pharmaceutical sector has seen a significant drop in recent years. Cannabis has risen from the shadows of stoner culture as a multi-billion dollar business with roots in industries such as healthcare, pharmaceuticals, consumer products, and agriculture.

Business 95

Business eCommerce Media Pharmaceutical 95

Veriheal

MARCH 1, 2022

The campaign manager of the ‘Yes on 109’ campaign that helped see the measure passed, Sam Chapman, told media sources, “There’s a huge breadth of expertise on this board from harm reduction experts to folks that have experience working with different populations that stand to benefit from having access to psilocybin therapy.

Therapy 98

Therapy Programs Microdosing Medicine 98

Cannabis Law Report

SEPTEMBER 14, 2021

Hamilton Morris is the creator and director of the documentary series Hamilton’s Pharmacopeia, in which he investigates the chemistry, history, and cultural impact of various psychoactive drugs. Mr Morris said: “For over a decade, Jason and I have worked together studying the chemistry and pharmacology of psychedelics.

Research and Development 52

Research and Development Therapy Pharmaceutical History 52

Cannabis Law Report

SEPTEMBER 29, 2022

The Therapeutic Goods Administration (TGA) issued 73 infringement notices totalling $972,360 between the medicinal cannabis companies MGC Pharmaceuticals Ltd, Cannatrek Ltd and Little Green Pharma Ltd. The infringements were for the alleged unlawful advertising of medicinal cannabis products on websites and social media platforms.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. History of compliance with regulations and policies governing government regulated marijuana programs. Criterion 2. Criterion 3.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

FEBRUARY 28, 2022

Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation. Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. Because they were criminalized for decades, the U.S. It contains five Parts.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Canna Care Docs

SEPTEMBER 18, 2020

Yes, you will be able to upload your records directly to your patient portal which you will receive access to. The District of Columbia may at some point extend their reciprocity law to allow for Virginia patients to utilize DC dispensaries in the future. History of Medical Marijuana in Virginia.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Canna Law Blog

NOVEMBER 27, 2021

Also, according to the DEA, “the history of human experience probably goes back several hundred years since DMT usage is associated with a number of religious practices and rituals.” Several months ago, Canada-based Algernon Pharmaceuticals submitted a request to U.S. California Psychedelic Law Update.

Therapy 88

Therapy Clinical Trials DEA Microdosing 88

Cannabis Law Report

JULY 20, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. History of compliance with regulations and policies governing government regulated marijuana programs. Criterion 2. Criterion 3.

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

JULY 28, 2021

This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies. The recent addition of KGK Science Inc. On behalf of: KETAMINE ONE.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

JULY 7, 2021

as the Company’s contract research division also places the company at the forefront of premium clinical research based on its 23-year history and extensive experience in pharmaceuticals, cannabis, and the emerging psychedelic medicine industries. The recent addition of KGK Science Inc. On behalf of: KETAMINE ONE.

Research and Development 98

Research and Development Treatment Therapy Banking 98

Cannabis Law Report

OCTOBER 19, 2019

Company boss Tomaž Frelih told Proactive Investors that it was attracted to the London NEX exchange as a way of accessing growth capital and demonstrating to investors that it is a ‘serious, structured business’. 200-Years Of History. pharmaceuticals business Freyherr d.o.o. pharmaceuticals business Freyherr d.o.o.

Cultivation 45

Cultivation Hemp Research and Development Pharmaceutical 45

Cannabis Law Report

NOVEMBER 14, 2019

Australia’s westernmost state is making it easier for patients to access medical cannabis. The changes will allow GPs to prescribe medical cannabis to patients but specialist approval will still be needed for children under 16 and patients with a history of drug abuse. Full story at [link].

Patients 45

Patients Access Medicine Pharmaceutical 45

Burns Levinson (Cannabusiness advisory)

OCTOBER 3, 2018

This marks the first time in history that the DEA has removed any type of cannabis from Schedule I, and clears the way for the sale of the first non-synthetic, cannabis-derived medicine to win federal approval. Therefore, it no longer meets the criteria for placement in Schedule I. While … Keep reading.

CBD 40

CBD DEA Epilepsy Pharmaceutical 40

The Cannigma

AUGUST 5, 2022

When antidepressants were first introduced in the mid-20 th century, they were a breakthrough in pharmaceuticals. But today, thanks to a combination of changing laws and attitudes and a building consensus of scientific research, there’s another, perhaps unexpected option – ketamine. The statistics on depression are startling.

Treatment 138

Treatment Research and Development Therapy Digestion 138

Cannabis Law Report

SEPTEMBER 8, 2021

The CertainT platform can be used across industries such as textiles, cannabis, military, leather, fertilizer, pharmaceuticals, personal care. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. About Flora Growth Corp. For Applied DNA: Investor contact: Sanjay M.

Supply Chain 96

Supply Chain Therapy Pharmaceutical Food 96

PrestoDoctor

OCTOBER 13, 2023

However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug. The dosage and treatment duration may vary depending on the patient’s specific condition and medical history. Moreover, the legality and accessibility of Marinol and medical cannabis can vary. Is Marinol Addictive?

THC 98

THC Chronic Pain Treatment Conditions 98

Cannabis Law Report

DECEMBER 14, 2019

Now, unless the patient is under 16 years old or has a history of drug abuse, medical practitioners in New South Wales can prescribe cannabis medicines without having to refer to a specialist. There’s also been a decrease in pricing pressure for medical cannabis patients throughout the country. Learn to profit from cannabis companies.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

CannaTech

NOVEMBER 19, 2019

That is being tolerated, but mostly the laws are very strict and enforced. It’s shocking, and what’s more, is that the authorities feel justified because it is illegal and don’t care what evidence is out there about its history here. Is there a history of traditional cannabis in Namibia?

History 80

History Research and Development Cannabis Education 80

CannaTech

NOVEMBER 19, 2019

That is being tolerated, but mostly the laws are very strict and enforced. It’s shocking, and what’s more, is that the authorities feel justified because it is illegal and don’t care what evidence is out there about its history here. Is there a history of traditional cannabis in Namibia?

History 76

History Research and Development Cannabis Education 76

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. Santé Cannabis is at the forefront of safe and supported patient access to complementary medicines. Caution Regarding Forward-Looking Information.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

OCTOBER 17, 2019

which aspects of the law are determined federally versus locally. which governmental bodies are responsible for regulating the law. What sets us apart from the rest of the world is that we’ve legalized cannabis for recreational use on a federal basis,” says Trina Fraser of Brazeau Seller Law (Ottawa, Ontario, Canada).

Law 40

Law Seed-To-Sale Hemp Recreational 40

SpeedWeed

JULY 31, 2021

Imagine that your quality of life depended on a specific medication — and due to a government shortage, you didn’t have access to it anymore. Determined to widen access to the plant for seropositive patients, Villaverde became the secretary of the Ananda Foundation , the medicinal branch of Club Cannábico Xochipilli.

Medicine 52

Medicine Patients Access Research and Development 52

Veriheal

AUGUST 14, 2023

I still wasn’t sure how the laws would treat growers, especially since I live in the bible belt. We still have plenty of things to fight for here in Oklahoma, but at least we have access to the plant now as patients. It stays that way because of the pharmaceutical industry lobbying. That’s really what counts!

Legalization 98

Legalization Strains Media Cannabis 98

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. But if that doctor has access to information from 40,000 patients it’s a different story.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It also has an extensive and diverse history of medicinal use. 2018 ; Frankhauser 2008 ). Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

Veriheal

AUGUST 31, 2020

Essay Summary: Although doctors’ offices are full of pamphlets and flyers about mainstream pharmaceuticals in both English and Spanish, there is a lack of information for Hispanic patients seeking relief with cannabis and CBD. . Essay: “The Nature of Hemp and Law: Hazy Regulation”. School: University of Maryland. Jack Devanna .

Research and Development 117

Research and Development Education Agriculture Patients 117